NCD Countdown 2030 Report

 

September 2020 | Update NCD Countdown 2030 Report | 2nd Edition Dear Aloyzio Thank you for registering to receive In Focus: NCDs. Following on from the NCD Countdown 2030 Report published in 2018, we are delighted to share with you the 2nd edition of the NCD Countdown 2030 report led by Imperial College London, World Health Organization, and the NCD Alliance, published in The Lancet ahead of the Global Week of Action on NCDs.  NCDs currently kill over 40 million people a year worldwide, making up seven out of ten deaths globally. 17 million of these deaths are of people younger than 70 years old and classed as premature; the great majority (15 million) of these deaths are between 30 and 70 years. Around the world, the risk of dying prematurely from preventable and largely treatable chronic diseases such as stroke, heart disease, and stomach cancer has declined steadily over the past decade, but death rates from other chronic diseases such as diabetes, lung cancer, colon cancer, and liver cancer are declining too slowly or worsening in many countries. Many countries are falling short or behind on their commitments to reducing premature mortality from chronic diseases, or non-communicable diseases (NCDs) by one third by 2030. Among high-income countries, only Denmark, Luxembourg, New Zealand, Norway, Singapore, and South Korea are on track to meet the SDG target for both men and women if they maintain or surpass their recent rates of progress. We hope you find the Countdown to be informative and helpful to your work. Yours sincerely, The Lancet P.S. Next week, we publish The Lancet NCDI Poverty Commission: bridging a gap in universal health care for the poorest billion, exploring the relation between poverty and NCDs. We would like to invite you to attend the Commission launch at a virtual event, which is free to attend with registration, on Tuesday, Sep 15, 2020. Register here.     RELATED CONTENT NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4 COVID-19: a new lens for non-communicable diseases     RELATED RESOURCES   Tracking global progress on non-communicable diseases Trends in the risk of premature death from the main four NCD groups from 2010 to 2016. View this Infographic

The Convergence of Infectious Diseases and Noncommunicable Diseases

Recomendado pela AMICOR Maria Ines Azambuja	10:39 (há 21 minutos)
para Docentes, eu

Assisti online a um seminario promovido pela Rockfeller Foundation sobre

Breaking Down Silos: The Convergence of Infectious Diseases and Noncommunicable Diseases 

O primeiro dia foi mais teórico-epidemiológico-científico (hipoteses de associção causal entre germes e doenças cronicas) e o segundo sobre como fazer serviços de saúde que funcionam verticalmente para tratamento de AIDS e TB, por exemplo, encamparem o tratamento de DCNT (diabetes, DCV)...

Neste segundo ponto, creio que estamos muito mais avançados no Brasil. A integralidade é uma realidade no SUS, na ponta do sistema. Mesmo assim, ainda há temor de que se se quebrarem muros o financiamento desapareça, como vimos nas reações a integrar politica de atenção ao HIV/AIDS a de outras doenças cronicas (Tb...)..

   

Mas também escrevo para divulgar para o grupo interessado em microbioma referências sobre o palestrante que mais interesse provocou no primeiro dia 

Rob Knight. Talvez alguem queira visitar San Diego...

https://docs.google.com/document/d/1BbGlGPdM4oUKFJ5WZIsAMsRBA1z3GHr1VcBbj1tOOOc/edit  

Ainda houve uma discussão interessante no final sobre porque o microbioma ganha tanto espaço em termos de expectativa de controle de doenças enquanto, por exemplo, os determinantes sociais de saúde - que todos concordaram que, se modificados, reduziriam a morte e o adoecimento -merecem menos entusiasmo... as respostas foram interessantes... desde a questão da terminologia - e Reddy, da Índia, introduziu a expressão "exposoma"- que dá modernidade à velhos conhecidos determinantes ambientais e comportamentais - passando por necessidade de melhorar a comunicação entre cientistas, políticos e financiadores, até questões de classe dos cientistas e de poder (ou falta dele) para influirem nisto.

Interessante também que a ex-ministra da Saúde  e Professora de Saúde Publica do Peru, Patricia Garcia identificou a corrupção como grande chaga nas politicas publicas de saúde e falou bastante sobre a necessidade de investirmos em pesquisa anti-corrupção. Também enfatizou que é impossível integrar agendas se a formação é cada vez mais especializada e se os financiadores não entenderem que precisam financiar praticas integradas e não doenças específicas. Gostei muito das contribuições dela.

Descobri também que os 55 países da Africa contituíram uma União Africana, aduaneira, comercial e de produção de insumos de saúde e de vigilância  (ou esta é a intenção) e tem agora um CDC Africa. Conforme seu coordenador, tudo funciona no papel, mas ainda sem repercussão para baixo...

Aqui a agenda do encontro para quem tiver interesse em buscar saber mais ...

http://nationalacademies.org/hmd/~/media/Files/Activity%20Files/PublicHealth/MicrobialThreats/2019-JUN-1/FMT%20Agenda%20Convergence%20NCD%20and%20ID%20Workshop%20FINAL%20v3.pdf  

Imagino que disponibilizarão algum documento, eventualmente...

NCD Alliance

NCD Alliance‏ @ncdalliance

@ncdalliance is celebrating #10years of leading progress in prevention & control of #NCDs! Our CEO @katiedain1 wants to say #thankyou to our founding members, and to all our members & supporters around the world #enoughNCDs

Syndemic

Time to radically rethink non-communicable diseases 

Published:May 11, 2019DOI:https://doi.org/10.1016/S0140-6736(19)31038-4

PlumX Met

    Richard Horton

That Commission defined a syndemic as a “synergy of epidemics”—components “co-occur in time and place, interact with each other to produce complex sequelae, and share common underlying societal drivers”
..........
Rachel ruefully noted, “the limitation of our own brains”: temporal discounting (lethal short-termism), non-linearity (tipping points that can precipitate extreme, rapid, and unpredictable change), and a strange phenomenon in which humans deploy psychological tricks to distance themselves from the risks around them. The result is that, “Almost everywhere in the world, we are doing a lousy job”. Although air pollution has now been added to the core risk factors driving NCDs, this welcome incremental addition is not enough. As Rachel's Taskforce showed, “NCDs are both cause and consequence of poverty”. The jeopardy presented by NCDs is amplified by poor education (SDG 4), gender inequalities (SDG 5), economic dysfunction (SDG 8), urban degradation (SDG 11), and unsustainable production and consumption (SDG 12). The unsolved paradox is that policies that would produce the greatest health impact receive the least attention. Why? Here is the alarming truth: our economies are incentivised to earn vast private wealth by increasing public risks for NCDs. Until that truth is accepted and addressed, NCDs will remain part of an unchecked planetary emergency.

NCDs - The Lancet

December 2018 | Wra 2018 in review: a renewed call for urgent and prioritised action on NCDs Dear Aloyzio With the launch of the Lancet Taskforce on NCDs and Economics in April, Richard Horton and I wrote that 2018 must be the year for action against NCDs. And so it has been, both internationally and here at The Lancet. Over the past year, we have been delighted to bring you the best scientific research and the strongest evidence to motivate global action to curb years lived with NCD-related disability and premature mortality. A first step in defeating NCDs is quantifying the burden. The 2017 Global Burden of Disease (GBD) Study demonstrates the rising global burden of premature mortality and from ischaemic heart disease, diabetes, cancers, and other NCDs, particularly in low-income and middle-income countries. The GBD Study papers highlight the increasing urgency for action against NCDs as they surpass infectious diseases as the leading cause of premature deaths. Indeed, GBD estimates that over half of all premature deaths could be avoided by controlling just four risk factors—high blood pressure, smoking, high blood glucose, and high body mass index. The Lancet NCD Countdown 2030 provides further granularity to the global NCD burden and expands analysis from the SDG target 3.4 to include all premature deaths under the age of 80 years and all NCDs, as well as showing that only a handful of countries are making sufficient progress to meeting target 3.4 by 2030. To ensure that the global targets are met, accountability must remain central to efforts to reduce the NCD burden. The Lancet NCD Countdown will continue to report premature deaths annually, and in future iterations will provide in depth analysis of risk factor control, policy implementation, and fiscal solutions to tackling the burden. 2018 has also seen expansion of the WHO four-by-four NCD strategy, recognising that good mental health is fundamental to achieving SDG3—good health and wellbeing. Our Commission on global mental health and sustainable developmentprovides a framework for sustainable mental health and recommendations for integrating mental health services with other healthcare priorities and for investing in both services for and research into improving mental health. Most importantly, global health communities must not and cannot operate in silos. The International AIDS Society-Lancet Commission: advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals emphasises that health services must be fully integrated and patient-centred to address both the communicable disease and NCD burdens, particularly in low-income and middle-income countries. The update to the Lancet Commission on Investing in Health also acknowledges the recent epidemiological shift toward NCDs. The Commissioners propose new global action initiatives to achieve a grand convergence of health for NCDs, in addition to tuberculosis, maternal and child health, and HIV/AIDs. Furthermore, the enormous and deadly burden of NCDs needs to be addressed not only on a global scale, but national governments must take responsibility. The Tsinghua-Lancet Commission on Healthy Cities in China reports worrying trends on increasing NCDs resulting from rapid urbanisation in Chinese mega cities. On a more positive note, the fifth report of the Lancet Standing Commission on Liver Disease in the UK reflects on progress made since the publication of the initial Commission report in 2014, as well as highlighting commercial determinants of liver disease, such as the alcohol and food industries, as targets for future campaigns. Thank you for following In Focus: NCDs throughout 2018. This edition of the newsletter is the final, regular update on Lancet NCD initiatives, but our work does not end here. As the NCD movement presses onward, so shall we. As the Lancetfamily of journals continues to publish the best evidence to transform policy in this critical area, we will keep you updated of new initiatives. In the meantime, stay in touch with The Lancet by following us on Twitter, including use of #LancetNCDs. You can also freely register to receive our weekly Table of Contents alerts or any of our Lancet Updates. Yours sincerely, Jennifer Sargent Senior Editor, The Lancet